Is this the prostate cancer test all men at risk should demand?

Too many men are getting the all-clear for prostate cancer when in fact they have the disease, say doctors, who are calling for an overhaul of testing techniques.

Professor Stephen Langley, a prostate cancer expert, blames the misdiagnoses on inaccurate biopsies.Under current guidelines from NICE (National Institute for Health and Care Excellence), men with abnormally high levels of prostate specific antigen (PSA), a protein produced by the prostate gland, should be offered a test called trans-rectal ultrasound (TRUS) biopsy.

Here, doctors take tissue samples by passing special needles via a probe in the rectum.Read more: Follow us: @MailOnline on Twitter | DailyMail on Facebook

Read the full article here